We explored the effects of two components of ischemia, hypoxia and glucose deprivation, on the jl-adrenergic receptor (fiAR)-adenylate cyclase system in a model of hypoxic injury in cultured neonatal rat ventricular myocytes. After 2 h ofhypoxia in the presence of 5 mM glucose, cell surface #AR density (3H-CGP-12177) decreased from 54.8±8.4 to 39±63 (SE) fmol/mg protein (n = 10, P < 0.025), while cytosolic #AR density ('25I-iodocyanopindolol IICYPI) increased by 74% (n = 5, P < 0.05). Upon reexposure to oxygen cell surface IAR density returned toward control levels. Cells exposed to hypoxia and reoxygenation without glucose exhibited similar alterations in #AR density.
ations in #AR density.
In hypoxic cells incubated with 5 mM glucose, the addition of 1 MM (-)-norepinephrine (NE) increased cAMP generation from 29.3±10.6 to 54.2±16.1 pmol/35 mm plate (n = 5, P < 0.025); upon reoxygenation cAMP levels remained elevated above control (n = 5, P < 0.05). In contrast, NE-stimulated cAMP content in glucose-deprived hypoxic myocytes fell by 31% (n = 5, P < 0.05) and did not return to control levels with reoxygenation. ,AR-agonist affinity assessed by (-)-isoproterenol displacement curves was unaltered after 2 h of hypoxia irrespective of glucose content. Addition of forskolin (100 MM) to glucose-supplemented hypoxic cells increased cAMP generation by 60% (n = 5; P < 0.05), but in the absence of glucose this effect was not seen.
In cells incubated in glucose-containing medium, the decline in intracellular ATP levels was attenuated after 2 h of hypoxia (21 vs . 40%, P < 0.05). Similarly, glucose supplementation prevented LDH release in hypoxic myocytes.
We conclude that (a) oxygen and glucose independently regulate 6dAR density and agonist-stimulated cAMP accumulation; (b) hypoxia has no effect on ,BAR-agonist or antagonist affinity; (c) 5 mM glucose attenuates the rate ofdecline in cellular ATP levels during both hypoxia and reoxygenation; and (d) glucose prevents hypoxia-induced LDH release, a marker of cell injury. (J. Clin 
Introduction
Recent approaches to the treatment of acute ischemia have attempted to favorably alter cardiac metabolism and thereby improve myocardial cell survival. With the onset of ischemia, morphological, functional, and metabolic changes occur in myocardial cells. After brief periods of reduced blood flow, reperfusion results in a prompt return of cardiac function and metabolism. Longer periods of reduced blood flow may cause myocardial function to be depressed for hours or days ("stunned myocardium") (1) . However, with prolonged ischemia, irreversible myocardial cell damage ensues (2) . The major determinants of the transition between reversible and irreversible injury include the severity of coronary blood flow reduction, the cellular concentrations of high energy phosphates and substrates, and the rate of metabolic waste removal from the heart (3-7).
Among the factors influencing the extent ofcell injury, hypoxia and glucose deprivation are of particular importance. Hearse and Chain reported a correlation between low P02 during anoxic myocardial perfusion and the fall of myocardial ATP concentration (3) . It was suggested that ATP depletion represents a marker of irreversible cell injury and could limit myocardial cell survival. Introduced a quarter century ago by Sodi-Pallares and co-workers, glucose-insulin-potassium (GIK) infusion represented an attempt to arrest myocardial damage during acute infarction (8) . Subsequent studies into the beneficial mechanism of GIK indicated that glucose reduced the use of free fatty acids thereby decreasing myocardial oxygen consumption and retarding progressive myocardial injury (9) . Nuclear magnetic resonance studies suggest that exogenously supplied glucose may supplement endogenous glycogen mobilization, delay glycogen depletion and prolong the production ofhigh energy phosphates required by myocardial cell metabolism (10) .
However, these studies have focused primarily on clinical and metabolic end points as an indirect reflection of myocardial cell survival during ischemia. The independent effects of two important elements of ischemia, hypoxia and glucose deprivation, on the viability of isolated myocytes and their effect on the f3-adrenergic receptor (,3AR)' adenylate cyclase system are largely unknown. In part this is due to intrinsic difficulties in pursuing these questions in the ischemic heart in vivo. Variables include the influences of sympathetic cardiac stimulation, elevated circulating catecholamine levels, a heterogenous cell population, and the lack of methods for producing a uniform ischemic insult. The results ofstudies using purified myocardial membranes prepared from in vivo ischemic myocardium to investigate the consequences ofacute ischemia or hypoxia on the ,BAR-adenylate cyclase system are inconsistent (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Recent observations in our laboratory suggest that variations in the preparation of purified membranes may, in part, explain these discrepancies (21) . Therefore, we used intact cultured neonatal rat ventricular myocytes to assess the independent effects of hypoxia and glucose deprivation on components of the fl-adrenergic receptor-adenylate cyclase system and myocardial cell viability.
Methods
Ventricular myocardial cell preparation. Primary cell cultures were composed ofsingle isolated ventricular myocytes prepared from hearts of l-d-old rats as previously described (22) . Cells were obtained by brief alternating cycles of room temperature trypsinization and mechanical dissociation. Cells were washed and preplated with 5% fetal calf serum to reduce the number of contaminating nonmyocardial cells. After 30 min nonattached myocardial cells were removed, counted, and diluted in MEM with HBSS containing 5% bovine calf serum and plated at a density of -550 cells per mm2 into either 100-or 35-mm Pyrex plates. This medium was supplemented with 1.5 MM B12 and 50 U/ml penicillin was used. The medium through day 3 contained 0.1 mM bromodeoxyuridine to prevent low level nonmyocardial cell proliferation as previously reported (22) . Medium was routinely changed on day 4.
Cell yield was 5-7 million per heart of which 90% were viable.
All cultures were kept at 370C in humidified air with 1% CO2 to maintain pH 7.3. The cultures contained > 90% myocardial cells and cell numbers were constant over time.
Induction of hypoxia. To assess the effect of hypoxia on components of the fl-adrenergic-adenylate cyclase system, 7-ml aliquots of MEM with Earle's BSS were gassed with 95% NJ5% CO2 for 30 min in an air-tight plexiglass gas perfusion chamber. Gas samples were obtained via an outlet port by suction directly into a Fyrite Gas Analyzer (United Technologies, Pittsburgh, PA). Samples measured before and at the completion of medium gassing verified the absence of ambient chamber O2. All experiments were performed on days 5-7 after plating. The method of exposing the myocytes to hypoxia was as follows: gassed 7-ml aliquots of medium were transferred by pipet to Pyrex culture dishes containing myocytes rinsed with medium to remove residual serum. Plates were then transferred to the gas perfusion chamber for varying time periods at 37°C. In Torr. Intact cells were used for analyses of 6-adrenergic receptor density and affinity and intracellular cAMP and ATP content and lactate dehydrogenase release (see below).
To assess the potential effect ofglucose deprivation on the #l-adrenergic receptor-adenylate cyclase system, glucose-free MEM-Earle's BSS was substituted for 5 mM glucose-containing MEM-Earle's BSS under both the normoxic and hypoxic experimental conditions described above.
Reoxygenation was accomplished by placing uncovered dishes from the gas perfusion chamber in a Forma Scientific Incubator (Marietta, OH) at ambient P02 for 2 h. At (24) .
To measure membrane and cytosolic jB-adrenergic receptor populations from the same cells under normoxic and hypoxic conditions, intact myocytes were washed three times with 1 mM Tris/2 mM EGTA and lysed in situ in this hypotonic buffer for 20 min at 4VC as previously described (25) . The resultant particulate preparation was harvested using a rubber spatula and placed in 18 X 100-mm polycarbonate tubes and centrifuged at 40,000 g for 30 min. The pellet was resuspended in 50 mM Tris HCl/l mM MgCl2, pH 7.4, and stored at -70°C; the supernatant of the original 40,000 g centrifugation was transferred to 16 x 102-mm polyallomer tubes (Beckman) and centrifuged at 125,000 g for 24 h at 4°C in a Beckman L350 ultracentrifuge. For assay, 80 Al ofeach cell fraction preparation was incubated with 10 s1 of(+)'251-iodocyanopindolol (ICYP), which has binding characteristics similar to (-)-'251-ICYP (26) , at a final concentration ranging from 20 to 200 pM, in a total volume of 100 Ml at 37°C, in 12 X 75-mm polypropylene tubes for 30 min., at which time the plateau ofthe binding reaction was reached. Nonspecific binding was assessed by the addition of 1 MM (-)-propranolol (final concentration). Binding reactions were terminated by the addition of 10-15 ml of 50 mM Tris HCl/10 mM MgCl2 and the contents immediately filtered through glass fiber filters (Whatman GF/C) and counted in a gamma counter (Beckman 5800) at an efficiency of 73%. All determinations were carried out in triplicate (membrane fractions) or duplicate (cytosolic fractions). Protein content was determined by the method of Lowry et al. (27) . For membranes, each assay tube contained 13-15 Ag protein and for cytosolic determinations, each tube contained 5-8 Ag protein.
For (-)-isoproterenol displacement curves a particulate fraction from normoxic and hypoxic cells was prepared as described above. 10 Ml of 1251-ICYP (20 pM final concentration) were incubated at 37°C for 30 min in the presence of varying concentrations of (-)-isoproterenol (10 nM to 100MM) after the reaction was initiated by the addition of80
Ml of the membrane preparation. Displacement experiments were performed in the presence and absence of 100MM GTP. The binding assay was performed as described above. Previous studies in our laboratory and by others (25, 28, 29) using these techniques have indicated that neonatal rat ventricular myocytes, like adult rat myocytes (30) , contain predominantly,61-adrenergic receptors.
cAMP Radioimmunoassay. The effect of hypoxia in the presence and absence of 5 mM D-glucose on (-)-norepinephrine-stimulated intracellular cAMP generation was determined according to a modification of a previously described method (31) . Briefly, myocardial cells were plated in 35-mm Pyrex dishes and subjected to normoxic or hypoxic conditions as described above. 5 min before the addition of varying concentrations of (-)-norepinephrine, 3-isobutyl-I-methylxathine (IBMX) was added to the medium to achieve a final concentration of I mM. After 5 min of incubation with (-)-norepinephrine, cells were eluted with 3 ml of95% ethanol, and the eluent transferred to 12 x 75-mm borosilicate glass tubes, air dried, and stored at 4VC for up to 1 mo, which did not affect the results. At the time of assay the pellet was thawed and resuspended in 300 AI 0.05 M NaOAc, pH 6.2; 100 AI of this resuspension or 100 Al of cAMP standard was added to 100 JAl of '25I-succinyl-cAMP tyrosine methyl ester tracer (6-12,000 cpm). 100 Ml of goat cAMP antibody in sodium acetate buffer containing 2 mg/ml bovine gamma globulin was then added in a final dilution of 1:240,000 and incubated overnight on ice; 1.5-ml polyethylene glycol-gamma globulin solution (160 mg polyethylene glycol per ml of 0.1% bovine gamma globulin solution) was added to each tube and the precipitated antibody-antigen complex centrifuged at 40,000 rpm (Sorvall TB3500; DuPont Co., Wilmington, DE) for 40 min. After aspiration of residual supernatant from this spin, the 125I-antigen-antibody complex was counted for 1 min in a gamma counter (Beckman 5800) at an efficiency of 73%. The results from two plates per condition, each analyzed in duplicate, were averaged for each data point and reported as pmol cAMP/35 mm plate, each of which contained 100-130,000 cells or 65-75 Ag protein.
Adenosine triphosphate assay. To assess the effect of hypoxia on intracellular ATP content in the presence and absence of 5 mM D-glucose, a fluorometric assay was used as described by Lowry and Passenau (32) . Myocytes were harvested by removing medium and 400 M1 of I M perchloric acid was added immediately. A 350-Ml aliquot was transferred to a microcentrifuge tube; the extract was neutralized with 3 M KOH/50 mM imidazole and stored at -70°C. On the day ofassay, the sample was thawed, vortexed, and centrifuged to pellet the KC104. 100 Ml ofsupernatant was added to 900 Ml ofATP reagent (50 mM Tris HCI, pH 8.1/1 mM MgCIJ0.2 mM glucose/0.02% BSA/0. I mM nicotinamide adenine dinucleotide phosphate/70 mU/ml glucose-6-phosphate dehydrogenase). The samples and the ATP standard curve were read at 340 nm before and after the addition of 10 Ml hexokinase (140 U/mg). ATP content was expressed as nmol per mg protein.
Lactate dehydrogenase assay. The effect ofhypoxia in the presence and absence of 5 mM D-glucose on cellular lactate dehydrogenase (LDH) release was assessed as follows: 5-7-d-old myocytes plated on 100 mm Pyrex dishes were washed with warm MEM-Earle's BSS to remove residual serum and then exposed to varying durations of hypoxia in 3 ml of MEM-Earle's BSS in the presence and absence of 5 mM n-glucose. At the end of the hypoxic period, medium was removed, vortexed, and stored briefly on ice. A 100-Ml aliquot was assayed for LDH activity using a Kodak Ektachem Multi-Channel Analyzer. Arbitrary 0 and 100% LDH release values were determined by assaying medium LDH after each designated time point under normoxic conditions and after a single -70°C freeze-thaw cycle. LDH was then expressed as a percentage of maximum LDH release.
Data analysis. Results are expressed as mean±SE and were compared using Student's t test for paired data; a P value of < 0.05 was considered significant. 
Results
The influence ofhypoxia alone on cell surface j-adrenergic receptor density. We first investigated the effect ofhypoxia in the presence of glucose on cell surface ,-adrenergic receptor density in intact ventricular myocytes using the hydrophilic radioligand 3H-CGP-12177. After 1 h of hypoxia cell surface fl-receptor density fell by 20% from 58.6±7.9 to 47.1±6.1 fmol/mg protein (n = 4, P < 0.02); antagonist Kd was unchanged from control. After 2 h of hypoxia f3-adrenergic receptor density fell by 27 .4% from 54.8±8.4 to 39.8±6.25 fmol/mg protein, an additional 8% decline from 1 h of hypoxia (n = 10; P < 0.025) (Fig. 1 ). Antagonist Kd was not significantly altered (2.6±0.84 vs. 2.05±0.65 nM, n = 10).
We then determined the effect ofreoxygenation on cell surface fl-adrenergic receptor density. In a separate series of experiments two groups ofmyocytes were exposed to 2 h of hypoxia; one group was assayed for fl-adrenergic receptor density with 3H-CGP-12177 at the end ofthe hypoxic exposure as described We observed that the 03-adrenergic receptor density in this fraction approximated the concentration in the initial pellet (68±18 vs. 53±12 fmol/mg protein, n = 4) ( Table I) .
In a parallel series of binding studies myocytes were incubated in a hypotonic lysing buffer consisting of 1 mM Tris/2 mM EDTA for 20 min, then scraped and centrifuged at 40,000 g for 30 min. The pellet was assayed for fl-adrenergic receptors; the supernatant was again ultracentrifuged at 125,000 g for 24 h and the pellet assayed. We observed that this fraction contained less than 10% of the fl-adrenergic receptors present in the initial pellet (250±29 vs. 23±4 fmol/mg protein, n = 5). Based on these results, which indicate that the method ofmembrane preparation significantly alters the results of,-adrenergic receptor determinations, we used the hypotonic lysis method of preparing membrane and cytosolic fractions.
Hypoxia causes translocation of,#-adrenergic receptors to a cytosolic fraction. To determine if the decline of cell surface ,B-adrenergic receptor density was attributable to receptor downregulation or degradation, we prepared membrane and cytosolic fractions as described above from myocytes exposed to 2 h of hypoxia in the absence ofglucose. Previous studies in this laboratory have documented that the pellet from 100,000g ultracentrifugation (cytosolic fraction) is enriched in fl-adren- ergic receptors after 4 h of (-)-isoproterenol-induced downregulation but lacks adenylate cyclase activity (25) . To confirm the purity of our sarcolemmal preparation, we measured Na+/ K+-ATPase activity (33) . Under normoxic conditions, Na+/ K+-ATPase activity in the membrane preparation was 48.7±3.9 umol/h and after 2 h ofhypoxia the value was 40±9.5
,umol/h (n = 7, P = NS, Fig. 2 ). In the cytosolic fraction Na+/ K+-ATPase activity was barely detectable in either normoxic or hypoxic preparations (0.55±0.37 vs. 0.51±0.33 gmol/h; n = 7, Fig. 2) . After 2 h of hypoxia ,B-adrenergic receptor density in the membrane fraction assessed by '25I-ICYP binding fell 20% from 250±29 to 200±23 fmol/mg protein (n = 5, P < 0.05) ( The influence ofhypoxia andglucose deprivation on (-)-norepinephrine-stimulated cAMP generation. We next asked whether hypoxia in the presence and absence of glucose would alter catecholamine-stimulated cAMP generation. We chose the naturally occurring neurotransmitter, (-)-norepinephrine (NE) for these studies. Preliminary studies revealed that incubation with 1 MM NE for 5 min maximally stimulated intracellular cAMP in the presence of 1 mM IBMX. The peak response to NE also occurred at 5 min in hypoxic cells either in the presence or absence of glucose. Therefore, intact myocytes were first exposed to glucose-free hypoxic medium for 2 h before stimulation with 1 uM NE for 5 min. Under these conditions NE-stimulated intracellular cAMP fell by 31% from 35.4±3.8 to 24.6±4.1 pmol/35-mm plate (P = 0.01, n = 5). Despite 2 h of reoxygenation NE-stimulated cAMP levels remained depressed at 23.6±1.9 pmol/35-mm plate. However, addition of 5 mM E-glucose at the onset of reoxygenation returned NE-stimulated cAMP levels to control values (33.4±4.8 vs. 30.5±2.7 pmol/35-mm plate; n = 5, P = NS, Fig. 3) .
The presence of5 mM D-glucose during hypoxia and reoxygenation had profound effects on NE-stimulated cAMP generation. After 2 h of hypoxia in glucose-supplemented medium, NE-stimulated cAMP content rose by 185% above control levels from 29.3±10.6 to 54.2±16.1 pmol/35-mm plate (P < 0.05, n = 5). After 2 h of reoxygenation in the presence of glucose, NE-stimulated cAMP levels remained above control at 44.8±12.3 pmol/35-mm plate (n = 5, P < 0.05, Fig. 3 ).
Because ofthe profound influence ofglucose on (-)-norepinephrine-stimulated cAMP content during hypoxia, we explored the possibility that this effect was mediated by enhanced f3-adrenergic receptor-agonist affinity. In membranes prepared from myocytes exposed to hypoxia in the presence and absence of glucose, (-)-isoproterenol displacement curves revealed no alteration in j3-adrenergic receptor-agonist affinity during hypoxia; furthermore, the presence or absence of glucose had no effect on agonist affinity (Fig. 4) . GTP (100 MAM) produced the expected rightward shift in the competition curve. Effects of hypoxia and glucose deprivation on forskolinstimulated cAMP generation. To determine if substrate depletion could be implicated in the observed decrease in NE-stimulated cAMP generation during hypoxia in the absence of glucose, we used forskolin, an agent which stimulates cAMP accumulation by direct interaction with the catalytic unit of adenylate cyclase and likely, in part, by interaction with the stimulatory guanine nucleotide regulatory protein (Gj) (34, 35) . Because maximal depression ofintracellular ATP and NEstimulated cAMP generation was observed after 2 h ofhypoxia in the absence ofglucose, experiments with forskolin were performed at this time point. As shown in the left panel of Fig. 5 , after 2 h of hypoxia in the absence of glucose, 100 MM forskolin-stimulated cAMP generation did not differ significantly from normoxic conditions. By contrast, after 2 h ofhypoxia in the presence ofglucose, forskolin-stimulated cAMP generation was increased over normoxic conditions (Fig. 5, right) . The effect ofhypoxia and glucose deprivation on intracellular adenosine triphosphate content. Because ofthe independent influence of hypoxia and glucose on (-)-norepinephrine-stimulated cAMP content, we asked if high energy phosphate content was similarly altered. As shown in Fig. 6 , after 2 h of exposure to glucose-free hypoxic medium, intracellular ATP levels fell by 40% from 36.1±2.8 to 21.6±2.5 nmol/mg protein (n = 7, P = 0.02). Despite reoxygenation ATP continued to decline to 10.8±2.8 nmol/mg protein (n = 7, P < 0.01 vs. control). The addition of glucose to hypoxic medium significantly attenuated this decline in ATP: after 2 h ofhypoxia ATP levels fell from 40.5±3.5 to 32.2±3.8 nmol/mg protein, a statistically insignificant downward trend. However, this level was significantly above the value obtained during exposure to glucose-free hypoxic medium (21.6±2.5 nmol/mg protein; n = 7, P < 0.05). With reoxygenation, ATP fell to 19.6±2.8 nmol/mg protein, a level that still significantly exceeded the reoxygenation value in the absence of glucose (10.8±3.9 nmol/mg protein; P < 0.01, n = 7). Therefore, the addition of 5 mM n-glucose to hypoxic medium provides substantial protection against the fall in intracellular ATP levels, but does not prevent a significant reduction in ATP observed upon reoxygenation.
Glucose protects against hypoxia-induced lactate dehy drogenase release. To assess the effect of glucose on myocyte viability after 2 h of hypoxia we also measured LDH release into the medium. For control cells LDH release was < 100 U/liter, irrespective ofglucose content. After 2 h of hypoxia in the absence of glucose, LDH release averaged 549±55 U/liter (n = 6; P < 0.025). This represented an 18% increase in LDH release when expressed as a percentage of maximum LDH achieved by the freeze-thaw method (2998±187 U/liter, n = 6). By contrast, levels produced by hypoxic cells supplemented with glucose remained < 100 U/liter. When LDH release was measured at intermediate time points of 30 and 60 min, enzyme release from either glucose-deprived or supplemented hypoxic cells remained < 100 U/liter. Therefore, glucose attenuates LDH release after prolonged hypoxia.
Glucose protects against hypoxia-induced decline in beating. As shown in Fig. 7 A, hypoxia caused a marked reduction in beating rates, which was significantly greater in glucose-deprived cells. Reoxygenation restored the beating rate to control levels in glucose-supplemented cells. Although the beating rate increased in glucose-deprived cells after 2 h ofreoxygenation, it was still significantly below control levels (Fig. 7 A) .
In conjunction with the measurement of beating rates, the proportion ofbeating cells was also assessed. As can be seen in Fig. 7 B, this measure followed a pattern similar to the alterations in absolute beating rate in response to hyoxia and reoxygenation in the presence or absence of glucose.
Discussion
The fl-adrenergic receptor-adenylate cyclase system is an im- this system may in part mediate the effects of ischemia by influencing contractile activity, arrhythmogensis, and myocardial cell survival (1 1, 12, 19, 20, 36) . Although it is well recognized that glucose can attenuate the effects of hypoxia (9, 10), previous in vivo studies did not address the separate effects of these two important components ofischemia, hypoxia and glucose deprivation, on the f3-adrenergic receptor-adenylate cyclase system and their impact on myocyte survival. To our knowledge, this is the first report to examine in detail the separate influences of hypoxia and glucose deprivation on alterations in components of the f3-adrenergic receptor-adenylate cyclase system and a marker ofcellular injury in intact ventricular myocytes. Our results suggest that hypoxia and glucose de- (38) . Beta-adrenergic receptors also exist in a cytoplasmic (light vesicle) domain, as defined by their ultracentrifugation sedimentation characteristics (20, 39, 40) . This population may serve as a reserve pool for receptor cycling to and from the cell surface (41) . Our data are the first to demonstrate that the hypoxia-induced fall in cell surface receptors is associated with a concomitant rise in a cytoplasmic #-receptor population.
This cytoplasmic preparation was obtained by 24-h ultracentrifugation of the supernatant from the membrane fraction.
Thus, the entire f3-adrenergic receptor population was analyzed and no cellular fraction was discarded. The increase in cytoplasmic receptor density suggests that hypoxia downregulates membrane-associated fl-adrenergic receptors to an intracellular location.
In contrast, Buja et al. (42) (21) . In the latter model, a crude membrane preparation that more completely represents the overall fl-adrenergic receptor population was used. These investigators noted a decrease in f-adrenergic receptor density after 30 min of coronary occlusion and duplicated previous findings of others if a "purified" membrane preparation was employed.
We observed, as did Marsh and Sweeney (38) , that reoxygenation was associated with a return of reduced f3-adrenergic receptor density to control levels. This suggests that myocytes exposed to hypoxia are still viable and that reoxygenation is associated with a return to the cell surface of a previously downregulated a-receptor population. Although it is an unlikely explanation, we cannot exclude the possibility of new f3-adrenergic receptor synthesis accounting for this return of receptors to the cell surface during reoxygenation.
Glucose independently regulates (-)-norepinephrine-stimulated cAMP accumulation. Several clinical trials have reported an improvement in hemodynamic measurements and reduced mortality in patients receiving intravenous glucose alone or in the form of a glucose infusion containing insulin and potassium during acute myocardial infarction (45) (46) (47) (48) . It is well established that within minutes after acute coronary occlusion metabolic changes result that, if prolonged, adversely affect myocardial cell survival. Glucose may enhance myocardial cell viability during an ischemic or hypoxic insult and reperfusion/ reoxygenation by supporting glycolytic ATP production, forestalling glycogen depletion, reducing free fatty acid production, increasing the rate of adenine nucleotide pool regeneration, and attenuating the shortening of action potential duration (6, 7, (49) (50) (51) (52) (53) (54) . In a recent report, Runnman et al. noted that enhanced use ofexogenous glucose improved cardiac function in an isolated rabbit interventricular septal preparation without increasing total glycolytic flux or tissue high energy phosphate levels (55) . However, these previous reports did not consider the potential favorable impact ofglucose on the maintenance of adenylate cyclase activity and the resultant agonist-stimulated cAMP production during hypoxia. We observed a significant decline in NE-stimulated cAMP generation after 2 h of glucose-free hypoxia which was unchanged after 2 h of reoxygenation (Fig.  3) . This finding is consistent with the observations of Heathers and co-workers who noted a decrease in (-)-isoproterenol-stimulated cAMP content after 60-120 min of hypoxia at a low glucose concentration (1 mM) in intact adult canine myocytes (43) . Our data show that the addition of 5 mM D-glucose not only dramatically reversed this decline but enhanced cAMP accumulation after the hypoxic insult. After 2 h ofhypoxia and reoxygenation in the presence of glucose, NE-stimulated cAMP levels were still elevated. Furthermore, the addition of glucose at the onset of reoxygenation after a glucose-free hypoxic interval returned agonist-stimulated cAMP generation toward control levels (Fig. 3) . It should be noted that in the absence of glucose, shorter periods of hypoxia, e.g., 30 min, had no effect on NE-stimulated cAMP accumulation (37±5 vs. 38±4 pmol cAMP/35 mm plate; n = 7, P = NS). The subsequent reduction in cAMP generation suggests that glucose delays or prevents the development ofthe abnormalities in signal transduction that we observed.
These observations are consistent with those of Marsh and Sweeney in an embryonic chick myocyte model (38 above levels stimulated by 1 ,uM NE. Thus, even in the absence of glucose, there was sufficient ATP to act as substrate for adenylate cyclase to catalyze nonadrenergic receptor-mediated cAMP generation. While alterations in f3-adrenergic receptor density and ATP concentration may influence cAMP generation, postreceptor mechanisms may be ofequal or even greater importance. Since forskolin bypasses the f3-adrenergic receptor and, in conjunction with G., acts directly on the catalytic unit of adenylate cyclase, one interpretation of our data is that hypoxia, especially in the presence ofglucose, may enhance G-protein-catalytic unit coupling, permitting more efficient signal transduction. Although the mechanism ofthis augmentation is not readily apparent from our data it may, in part, be due to the beneficial effect of glucose supplementation on protein kinasedependent substrate phosphorylation or on membrane stability (see below).
Glucose attenuates thefall in adenosine triphosphate levels.
Compared with ATP produced in mitochondria, which use oxidative phosphorylation, ATP generated by glycolysis may preferentially support specific sarcolemmal-associated functions and maintain cellular integrity (7, 50, 52, 53, 58) . Moreover, compared with inhibition of oxidative metabolism, inhibition of glycolytic pathways during low flow ischemia results in accelerated enzyme release and a more rapid onset of myocardial contracture (7, 50, 52) . Reports in cultured avian myocytes have extended these observations to suggest that rates of glycolysis are closely linked to maintenance of normal membrane depolarization and contraction during inhibition of oxidative phosphorylation (50, 59) . Compartmentalization of ATP generated from exogenous glucose versus endogenous glycogen has been demonstrated in vascular smooth muscle (60) and postulated to occur in vivo in ischemic myocardium (61) . In perfused hypoxic rat hearts and rabbit interventricular septum (7, 54) and in isolated adult rat myocytes (62), glucose plays a special role in the preservation ofcell viability, morphology, ATP concentration, and in forestalling intracellular enzyme release. This beneficial effect extends to the preservation of intracellular pH and myocardial tension development (54) .
It has been proposed that key glycolytic enzymes present in the cell membrane or attached to the cytoskeleton use exogenous glucose to produce glycolytic ATP (63) , and this "compartmentalized" ATP may preferentially maintain cell membrane integrity and function and thus ultimately improve cell survival. Our observation that 5 mM D-glucose significantly attenuated the hypoxia-induced fall in ATP at 1 and 2 h of hypoxia and after reoxygenation is consistent with an increase ATP generated by glycolysis during hypoxia (62, 63) and may directly relate to our observation that glucose supplementation during hypoxia-prevented LDH release. This may in part also explain the fall in NE-stimulated cAMP accumulation after hypoxia in the absence of glucose as compared with the increase in cAMP stimulated by NE in the presence of glucose.
Further investigations are required to define the possible contribution of ATP compartmentalization to the maintenance or enhancement of membrane-bound enzyme activity. However, the fall in NE-stimulated cAMP content does not appear to be due to reduced ATP levels alone, because forskolin-stimulated (postreceptor-mediated) cAMP exceeded NEstimulated (receptor-mediated) cAMP generation under similar hypoxic conditions, regardless of glucose content. In this connection, Heathers et al. (43) recently proposed that hypoxia in the absence of glucose uncouples the fl-adrenergic receptor from the adenylate cyclase complex thereby altering receptormediated signal transduction. Our observation that hypoxia, irrespective ofglucose content, does not influence fl-adrenergic receptor affinity for (-)-isoproterenol leads us to suggest that the G-protein-catalytic unit interaction may be the site of uncoupling.
The objective of this study was to determine the independent effects of two components of ischemia, hypoxia and glucose deprivation, on elements of the f3-adrenergic receptoradenylate cyclase system in isolated cultured cardiac myocytes. Extrapolation of our results to in vivo models of ischemia should be done with caution. Clearly, the accumulation ofmetabolic products of ischemia and the effects of altered pH and external workload on the intact heart undoubtedly influence the effects of ischemia on the individual myocyte. However, exclusion of these confounding factors is important to further investigations of the precise determinants and relative contributions of hypoxia and glucose deprivation to cell injury and survival.
